Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Barone

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Medicine|July 26, 2014
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone miceFrancesca Ferrera, Daniela Fenoglio, Maurizio Cutolo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2018
<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patientsPaola Caroli, Israel Sandler, Federica Matteucci, et al.
Insights Into Imaging|August 31, 2014
The azygos vein pathway: an overview from anatomical variations to pathological changesSara Piciucchi, Domenico Barone, Stefano Sanna, et al.
BMC Cancer|November 2, 2014
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?Alberto Farolfi, Elisa Carretta, Corradina Della Luna, et al.
The Oncologist|July 27, 2014
Taxanes as a risk factor for acute adverse reactions to iodinated contrast media in cancer patientsAlberto Farolfi, Corradina Della Luna, Angela Ragazzini, et al.
La Radiologia Medica|July 3, 2023
Patient centered radiology: investigating 3 Tesla whole body MRI acceptance in cancer patientsAlice Rossi, Andrea Prochowski Iamurri, Danila Diano, et al.
Scientific Reports|March 2, 2022
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumabMichela Palleschi, Andrea Prochowski Iamurri, Emanuela Scarpi, et al.
International Journal of Molecular Sciences|December 6, 2017
Immunotherapy for Prostate Cancer: Where We Are HeadedGiuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, et al.
Bioelectromagnetics|March 14, 2002
Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic fieldsSanti Tofani, Marcella Cintorino, Domenico Barone, et al.
Frontiers in Oncology|January 21, 2026
Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trialMonica Celli, Roberta Gunelli, Fabio Ferroni, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Medicine|July 26, 2014
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone miceFrancesca Ferrera, Daniela Fenoglio, Maurizio Cutolo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2018
<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patientsPaola Caroli, Israel Sandler, Federica Matteucci, et al.
Insights Into Imaging|August 31, 2014
The azygos vein pathway: an overview from anatomical variations to pathological changesSara Piciucchi, Domenico Barone, Stefano Sanna, et al.
BMC Cancer|November 2, 2014
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?Alberto Farolfi, Elisa Carretta, Corradina Della Luna, et al.
The Oncologist|July 27, 2014
Taxanes as a risk factor for acute adverse reactions to iodinated contrast media in cancer patientsAlberto Farolfi, Corradina Della Luna, Angela Ragazzini, et al.
La Radiologia Medica|July 3, 2023
Patient centered radiology: investigating 3 Tesla whole body MRI acceptance in cancer patientsAlice Rossi, Andrea Prochowski Iamurri, Danila Diano, et al.
Scientific Reports|March 2, 2022
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumabMichela Palleschi, Andrea Prochowski Iamurri, Emanuela Scarpi, et al.
International Journal of Molecular Sciences|December 6, 2017
Immunotherapy for Prostate Cancer: Where We Are HeadedGiuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, et al.
Bioelectromagnetics|March 14, 2002
Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic fieldsSanti Tofani, Marcella Cintorino, Domenico Barone, et al.
Frontiers in Oncology|January 21, 2026
Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trialMonica Celli, Roberta Gunelli, Fabio Ferroni, et al.
Pageof 5